These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 181004)

  • 21. Pharmacodynamic interactions among gluco-, mineralo- and glucomineralocorticoids, pregnenolone-16alpha-carbonitrile and various drugs.
    Szabo S; Kourounakis P; Selye H; Da Silva O
    J Pharmacol Exp Ther; 1974 Jan; 188(1):45-54. PubMed ID: 4203374
    [No Abstract]   [Full Text] [Related]  

  • 22. Lithium-induced increase in the metabolism of benzo[a]pyrene and drugs in rat liver.
    Feuerstein G; Govrin H; Kapitulnik J
    Biochem Pharmacol; 1979 Nov; 28(21):3167-70. PubMed ID: 118760
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of pregnenolone-16 alpha-carbonitrile and other microsomal enzyme inducers on drug metabolism and some parameters of adjuvant induced disease in rats.
    Kourounakis P; Hadjipetrou-Kourounakis L
    Pharm Acta Helv; 1984; 59(12):348-52. PubMed ID: 6522414
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of adrenocorticotropin (ACTH) upon the drug response of intact and adrenalectomized rats.
    Szabo S; Kourounakis P; Selye H
    Can J Physiol Pharmacol; 1973 Mar; 51(3):169-74. PubMed ID: 4350179
    [No Abstract]   [Full Text] [Related]  

  • 25. [Contribution to the study of the metabolism of zoxazolamine in the rodents].
    Buchel L
    Arch Sci Physiol (Paris); 1971; 25(1):19-45. PubMed ID: 5562527
    [No Abstract]   [Full Text] [Related]  

  • 26. Restoration of impaired drug metabolism of rats with adjuvant induced disease by two steroids with different influence on drug biotransformation.
    Kourounakis PN; Rekka E; Hadjipetrou-Kourounakis L
    Pharmazie; 1991 Oct; 46(10):727-9. PubMed ID: 1803389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross inhibition of drug metabolism by drug metabolites. Increase of zoxazolamine paralysis time by the major metabolite of diphenylhydantoin.
    Lubawy WC; Kostenbauder HB; Stavchansky SA
    Res Commun Chem Pathol Pharmacol; 1974 May; 8(1):75-82. PubMed ID: 4847907
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of dibromotetrafluoroethane inhalation on hepatic drug metabolism in mice.
    Murphy JP; Van Stee EW; Back KC
    Biochem Pharmacol; 1973 Nov; 22(22):2843-51. PubMed ID: 4761555
    [No Abstract]   [Full Text] [Related]  

  • 29. Metabolism of drugs in old rats. II. Metabolism in vivo and effect of drugs in old rats.
    Kato R; Takanaka A
    Jpn J Pharmacol; 1968 Dec; 18(4):389-96. PubMed ID: 5304857
    [No Abstract]   [Full Text] [Related]  

  • 30. Modification of drug metabolic processes by compounds which intervene with the function of cytochrome P-450 as a mono-oxygenase and as an oxidase.
    Tani E; Rekka E; Iconomidis G; Kourounakis PN
    Arzneimittelforschung; 1989 Nov; 39(11):1399-402. PubMed ID: 2619770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucocorticoid anorexia in rats.
    Simpson CW; Dicara LV; Wolf G
    Pharmacol Biochem Behav; 1974; 2(1):19-25. PubMed ID: 4828480
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of the 1-keto and 1-hydroxy derivatives of 3-methylcholanthrene upon liver drug metabolizing enzyme activity.
    Bresnick E; Smith S; Seibert RA
    Biochem Pharmacol; 1970 Aug; 19(8):2469-74. PubMed ID: 5520604
    [No Abstract]   [Full Text] [Related]  

  • 33. Hepatic drug metabolism in vitro in the horse.
    Yeary RA; Gerken D
    Biochem Pharmacol; 1971 Nov; 20(11):3219-21. PubMed ID: 5132124
    [No Abstract]   [Full Text] [Related]  

  • 34. Hepatic drug metabolism in retinol-deficient rats.
    Colby HD; Kramer RE; Greiner JW; Robinson DA; Krause RF; Canady WJ
    Biochem Pharmacol; 1975 Sep; 24(17):1645-6. PubMed ID: 1191323
    [No Abstract]   [Full Text] [Related]  

  • 35. Stimulatory effect of 6-aminochrysene and congeners on zoxazolamine metabolism.
    Donelli MG; Garattini S
    Biochem Pharmacol; 1971 Aug; 20(8):2049-55. PubMed ID: 5137960
    [No Abstract]   [Full Text] [Related]  

  • 36. Sex differences in the effects of abnormal physiological states on the metabolism of drugs by rat liver microsomes.
    Kato R; Gillette JR
    J Pharmacol Exp Ther; 1965 Nov; 150(2):285-91. PubMed ID: 4285416
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of age on the induction of in vitro drug metabolism by pregnenolone-16 alpha-carbonitrile (PCN); effect of age and PCN on immune responses.
    Hadjipetrou-Kourounakis L; Yiangou M; Kourounakis P
    Pharmazie; 1987 Oct; 42(10):677-80. PubMed ID: 3325990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of novel anti-inflammatory ethanolamine derivatives with antioxidant properties on drug metabolising enzymes.
    Andreadou I; Rekka EA; Kourounakis PN
    Eur J Drug Metab Pharmacokinet; 2003; 28(1):7-10. PubMed ID: 14503659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms in the potentiation and inhibition of pharmacological actions of hexobarbital and zoxazolamine by glycofurol.
    Yasaka WJ; Sasame HA; Saul W; Maling HM; Gillette JR
    Biochem Pharmacol; 1978; 27(24):2851-8. PubMed ID: 736977
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of phenobarbital, 3-methylcholanthrene, and pregnenolone-16 alpha-carbonitrile on the N-demethylation and O-de-ethylation of [6-H3]ethylmorphine.
    Duquette PH; Peterson FJ; Erickson RR; Holtzman JL
    Drug Metab Dispos; 1981; 9(5):483-4. PubMed ID: 6117451
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.